$700M opioid treatment settlement reached by 6 states
New York state and five others reached a $700 million settlement Wednesday with drug distributor Reckitt Benckiser following a probe into the company’s role in the nation’s ongoing opioid epidemic, according to New York Attorney General Letitia James. The $700 million payment is a part of a larger $1.4 billion settlement that had been agreed upon back in July over allegations that the drug distributor had improperly advertised a drug to treat opioid addiction. Claims against Reckitt Benckiser's former pharmaceuticals business, Indivior, allege that the company carried out an “illegal scheme” to boost the sales of Suboxone, an opioid addiction treatment drug.
New York state and five others reached a $700 million settlement Wednesday with drug distributor Reckitt Benckiser following a probe into the company’s role in the nation’s ongoing opioid epidemic, according to New York Attorney General Letitia James. The $700 million payment is a part of a larger $1.4 billion settlement that had been agreed upon back in July over allegations that the drug distributor had improperly advertised a drug to treat opioid addiction. Claims against Reckitt Benckiser's former pharmaceuticals business, Indivior, allege that the company carried out an “illegal scheme” to boost the sales of Suboxone, an opioid addiction treatment drug.
No hay comentarios:
Publicar un comentario